1 janv. 2015 - (Varma et al., 2015)
Description:
The introduction of intravitreal vascular endothelial growth factor (VEGF) inhibition in 2006 hugely reduced legal blindness rates and achieved considerable improvements in vision in neovascular AMD and diabetic macular edema (DME)Ajouté au bande de temps:
Date:
1 janv. 2015
Maintenaint
~ Il y a 10 ans